Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy

Publisher： Karger

E-ISSN： 1421-9670|19|1|1-6

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.19, Iss.1, 1999-03, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beneficial Effect of Combination Therapy with an Angiotensin II Receptor Antagonist and Angiotensin-Converting Enzyme Inhibitor on Overt Proteinuria in a Patient with Type 1 Diabetic Nephropathy

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 529-530

Karger

Access to resources Recommend Favorite

Comparison between the Angiotensin II Receptor Antagonist Candesartan Cilexetil and the Angiotensin-Converting Enzyme Inhibitor Trandolapril in Microalbuminuria of Patients with Early Diabetic Nephropathy

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 247-247

Karger

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Receptor Antagonist and Calcium Antagonist on Urinary Podocytes in Patients with IgA Nephropathy

By  

American Journal of Nephrology, Vol. 20, Iss. 5, 2000-11 ,pp. : 373-379

Karger

Access to resources Recommend Favorite

Antiproteinuric Effect of an Angiotensin II Receptor Antagonist in Membranous Nephropathy

By  

Nephron, Vol. 88, Iss. 2, 2001-05 ,pp. : 183-184

Karger

Access to resources Recommend Favorite

Renoprotective Effects of Various Angiotensin II Receptor Blockers in Patients with Early-Stage Diabetic Nephropathy

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 3, 2010-06 ,pp. : 213-220

Karger

Access to resources Recommend Favorite